<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>63(5)</volume><submitter>Balasubramaniam D</submitter><pubmed_abstract>Triglycerides (TG) are required for fatty acid transport and storage and are essential for human health. Angiopoietin-like-protein 8 (ANGPTL8) has previously been shown to form a complex with ANGPTL3 that increases circulating TG by potently inhibiting LPL. We also recently showed that the TG-lowering apolipoprotein A5 (ApoA5) decreases TG levels by suppressing ANGPTL3/8-mediated LPL inhibition. To understand how LPL binds ANGPTL3/8 and ApoA5 blocks this interaction, we used hydrogen-deuterium exchange mass-spectrometry and molecular modeling to map binding sites of LPL and ApoA5 on ANGPTL3/8. Remarkably, we found that LPL and ApoA5 both bound a unique ANGPTL3/8 epitope consisting of N-terminal regions of ANGPTL3 and ANGPTL8 that are unmasked upon formation of the ANGPTL3/8 complex. We fur</pubmed_abstract><journal>Journal of lipid research</journal><pagination>100198</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9036128</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif.</pubmed_title><pmcid>PMC9036128</pmcid><pubmed_authors>Fitchett JR</pubmed_authors><pubmed_authors>Siegel RW</pubmed_authors><pubmed_authors>Konrad RJ</pubmed_authors><pubmed_authors>Day JW</pubmed_authors><pubmed_authors>Heng AR</pubmed_authors><pubmed_authors>Schroeder O</pubmed_authors><pubmed_authors>Jones BE</pubmed_authors><pubmed_authors>Chen YQ</pubmed_authors><pubmed_authors>Austin AK</pubmed_authors><pubmed_authors>Balasubramaniam D</pubmed_authors><pubmed_authors>Qian YW</pubmed_authors><pubmed_authors>Russell AM</pubmed_authors><pubmed_authors>Zhen EY</pubmed_authors><pubmed_authors>Davies J</pubmed_authors><pubmed_authors>Glaesner W</pubmed_authors><pubmed_authors>Beyer TP</pubmed_authors><pubmed_authors>Ehsani M</pubmed_authors></additional><is_claimable>false</is_claimable><name>An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif.</name><description>Triglycerides (TG) are required for fatty acid transport and storage and are essential for human health. Angiopoietin-like-protein 8 (ANGPTL8) has previously been shown to form a complex with ANGPTL3 that increases circulating TG by potently inhibiting LPL. We also recently showed that the TG-lowering apolipoprotein A5 (ApoA5) decreases TG levels by suppressing ANGPTL3/8-mediated LPL inhibition. To understand how LPL binds ANGPTL3/8 and ApoA5 blocks this interaction, we used hydrogen-deuterium exchange mass-spectrometry and molecular modeling to map binding sites of LPL and ApoA5 on ANGPTL3/8. Remarkably, we found that LPL and ApoA5 both bound a unique ANGPTL3/8 epitope consisting of N-terminal regions of ANGPTL3 and ANGPTL8 that are unmasked upon formation of the ANGPTL3/8 complex. We fur</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-26T15:23:35.144Z</modification><creation>2025-04-06T14:52:32.333Z</creation></dates><accession>S-EPMC9036128</accession><cross_references><pubmed>35307397</pubmed><doi>10.1016/j.jlr.2022.100198</doi></cross_references></HashMap>